Product NDC: | 50222-403 |
Proprietary Name: | Dovonex |
Non Proprietary Name: | Calcipotriene |
Active Ingredient(s): | .05 mg/mL & nbsp; Calcipotriene |
Administration Route(s): | TOPICAL |
Dosage Form(s): | SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 50222-403 |
Labeler Name: | LEO Pharma Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA020611 |
Marketing Category: | NDA |
Start Marketing Date: | 19970601 |
Package NDC: | 50222-403-60 |
Package Description: | 40 CARTON in 1 CASE (50222-403-60) > 1 BOTTLE in 1 CARTON > 60 mL in 1 BOTTLE |
NDC Code | 50222-403-60 |
Proprietary Name | Dovonex |
Package Description | 40 CARTON in 1 CASE (50222-403-60) > 1 BOTTLE in 1 CARTON > 60 mL in 1 BOTTLE |
Product NDC | 50222-403 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Calcipotriene |
Dosage Form Name | SOLUTION |
Route Name | TOPICAL |
Start Marketing Date | 19970601 |
Marketing Category Name | NDA |
Labeler Name | LEO Pharma Inc. |
Substance Name | CALCIPOTRIENE |
Strength Number | .05 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Vitamin D [Chemical/Ingredient],Vitamin D Analog [EPC] |